Volibo R 0.3/0.5 Tablet

Volibo R 0.3/0.5 Tablet – Dual-Mechanism Glucose Control for Type 2 Diabetes Volibo R 0.3/0.5 Tablet is a powerful combination therapy developed to support adults living with type 2 diabetes mellitus. By addressing both insulin release and carbohydrate absorption, it offers effective control of post-meal blood sugar spikes. This formulation is recommended when single-drug therapy or dietary adjustments are insufficient to maintain optimal glucose levels. Volibo R 0.3/0.5 Tablet contains two clinically proven ingredients: Repaglinide stimulates insulin production from the pancreas, particularly in response to meals, helping lower elevated blood glucose levels quickly. Voglibose slows the digestion of complex carbohydrates in the intestine, minimizing rapid increases in blood sugar after eating. Together, these active agents provide a synergistic effect that improves overall glycaemic control and helps reduce the risk of long-term diabetes-related complications. Key Benefits: Targets postprandial hyperglycemia with precision, encourages insulin release only when needed, reducing the chance of unnecessary lows, helps prevent blood sugar spikes after meals by delaying carbohydrate breakdown, supports long-term glucose stability, minimizing the risk of kidney, nerve, and cardiovascular complications, complements dietary efforts and physical activity for better diabetes management, can delay or reduce dependence on insulin when used as part of a comprehensive care plan. Uses: Volibo R 0.3/0.5 Tablet is indicated for managing Type 2 Diabetes Mellitus in adults, enhancing post-meal blood sugar regulation, improving glycaemic control when used alongside a balanced diet and exercise. How to Take: Take the tablet 30 minutes before a meal. Use once or twice daily, as directed by your physician. Swallow whole with water — do not chew, crush, or break. Maintain a consistent schedule for best blood sugar control. Always follow the prescribed dosage and instructions from your healthcare provider. Do not discontinue without medical advice, even if you feel well. Side Effects: While generally well-tolerated, some users may experience abdominal bloating or discomfort, diarrhea or loose stools, flatulence, mild nausea or indigestion, occasional hypoglycemia (especially when combined with other anti-diabetic agents). If symptoms persist or interfere with daily life, consult your doctor. Severe or allergic reactions are rare but should be addressed immediately. Precautions & Warnings: Inform your doctor if you are pregnant, breastfeeding, or planning to conceive. Disclose any history of kidney or liver disease. Not suitable for patients with type 1 diabetes or those experiencing diabetic ketoacidosis. Avoid use if allergic to repaglinide or voglibose. Inform your healthcare provider about any other medications or supplements you’re taking. Lifestyle & Dietary Considerations: Focus on whole grains, fresh vegetables, and high-fiber foods. Minimize intake of processed sugars and saturated fats. Engage in 150 minutes of moderate activity or 75 minutes of intense exercise weekly. Reduce stress levels, as stress can raise blood sugar. Maintain a healthy BMI and keep blood pressure within normal range. Storage: Store in a cool, dry location away from direct heat or light. Ideal storage temperature: 10°C to 25°C, but not exceeding 30°C. Keep out of reach of children and pets. Overdose: Taking more than the recommended dose may lead to undesirable effects such as low blood sugar or gastrointestinal upset. In case of accidental overdose, seek immediate medical assistance. Drug Interactions: Certain drugs can affect how Volibo R 0.3/0.5 Tablet works. Avoid or consult your doctor if you are taking Gemfibrozil, Gatifloxacin, or consuming grapefruit juice. Regular monitoring and consultation with your healthcare provider are essential for safe use. Therapeutic Class: Category: Oral Anti-Diabetics; Class: Alpha-glucosidase inhibitor + Meglitinide analog. Product Variants & Keywords: Volibo R 0.3/0.5 Tablet, Volibo R Tablet for diabetes, Repaglinide and Voglibose Tablet, Volibo R blood sugar control, Post-meal glucose medicine Volibo R.